Literature DB >> 30804127

Predictors of Postpartal Retained Products of Conception.

Fabinshy Thangarajah1,2, Magdalena Brunner3, Caroline Pahmeyer3, Julia Caroline Radosa4, Christian Eichler3,2, Sebastian Ludwig3, Bernd Morgenstern3, Peter Mallmann3.   

Abstract

BACKGROUND: Retention of products of conception (RPOC) following delivery is rare. Clinicians often have the impression that a high proportion of patients with sonographically suspected RPOC following surgery have a negative histopathology. Hence, we aimed to report our single-center experience with suspected RPOC and histopathological outcome after surgery. PATIENTS AND METHODS: In this retrospective analysis, patients who underwent surgery due to suspected postpartum RPOC were analyzed for potential predictive clinical and sonographic parameters.
RESULTS: A total of 32 patients with histopathologically-confirmed RPOC were compared with 21 patients with a negative histopathological report for RPOC. Endometrial hyperechogenic mass and clinical parameters such as pain, fever and bleedings were not predictive for RPOC. Increased age (p=0.001) and vaginal delivery (p=0.040) were significantly associated with RPOC.
CONCLUSION: Clinical presentation alone is not predictive for RPOC. Vaginal delivery and younger age seem to be a risk factor and therefore have to be considered in patients with suspected RPOC. Copyright
© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Delivery; RPOC; curretage

Mesh:

Year:  2019        PMID: 30804127      PMCID: PMC6506319          DOI: 10.21873/invivo.11496

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  1 in total

1.  The Histological Spectrum Reported on Evacuated Endometrial Tissue From Patients With Secondary Postpartum Hemorrhage: A Pilot Study.

Authors:  Isaac A Babarinsa; Samir A Al Hyassat; Salwa M Abu Yacoub; Stephen W Lindow
Journal:  Cureus       Date:  2022-08-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.